In Depth 27 Jun 2024
The 2024 drug approval list: Eight new treatments you should know about
In this article, we take a look at eight much-anticipated drugs that have been approved by regulators so far this year.
mRNA technology
- Latest Posts
Best in Biotech 11 Apr 2024
Seven companies leading the mRNA revolution in biotechnology
Here are seven mRNA biotechs that have raised funds in recent years to push their candidates ahead through preclinical and clinical trials.
Best in Biotech 9 Jan 2024
Four Pune-based biotech companies you should know about
Explore Pune’s dynamic biotech landscape and delve into the innovative work of the city’s most prominent biotech companies!
Best in Biotech 20 Dec 2023
Wrapping up 2023: A recap of top biotech moments of this year
2023 has been an exciting year for the industry. Here are some of the most notable biotech developments in 2023.
Best in Biotech 7 Nov 2023
Eight biotech companies tackling infectious diseases head-on
Infectious diseases are diseases that are caused by pathogens that enter the body, hijack the body’s immune system and multiply, causing an infection. Five of the deadliest infectious diseases are measles, tuberculosis, malaria, diarrhoeal disease and influenza, according to the World Economic Forum. While Our World in Data statistics suggest that there has been almost […]
Podcast 29 Sep 2023
Beyond Biotech podcast 65 – Disease X and pandemic preparedness
Disease X, a concept shrouded in mystery, represents the unknown pathogens that could unleash future epidemics or pandemics. In the wake of recent global health crises, our understanding of the profound impact of those pandemics has deepened. On this week’s podcast, we have a conversation with Hamilton Bennett, who led Moderna’s mRNA-1273 COVID-19 vaccine development […]
ADVERTISEMENT
ADVERTISEMENT
In Depth 16 Aug 2023
Can a vaccine be the solution to the surge in melanoma cases caused by the climate crisis?
Melanoma is the most serious type of skin cancer, and is primarily caused by too much exposure to ultraviolet (UV) light – in the U.K., around 85% of melanomas are thought to be caused by too much ultraviolet radiation. And, unfortunately, because of this, the surge in global temperatures caused by the climate crisis is […]
Opinion 11 Jul 2023
Unlocking the power of mRNA technology
By Yochi Slonim, CEO and co-founder of Anima Biotech mRNA technology has gained widespread recognition due to its role in the development of vaccines, such as those used against COVID-19; however, the scope of mRNA extends far beyond vaccines, offering a range of applications for addressing different conditions. Vaccines represent a notable application of mRNA […]
News and Trends 11 Jul 2023
Inhaled mRNA medicines redefine respiratory disease treatment
By Carsten Rudolph, co-founder and CEO of Ethris Advancements in mRNA technology have led to the development of inhaled mRNA medicines, which hold tremendous potential for revolutionizing the treatment of respiratory diseases, an area with high unmet needs. However, the primary hurdle in its clinical application lies in the identification of a delivery system that […]
In Depth 10 Jul 2023
“Ready-to-use” enzymatically produced cell-free synthetic DNA in mRNA manufacturing
By Ashish Dhir, PhD and Amy Walker, PhD, 4basebio The pace, efficacy and scalability with which the success of mRNA vaccines against COVID-19 was demonstrated opened endless possibilities for mRNA medicine in broad areas of infectious diseases, cancers, protein-encoding replacement therapies. The advantages of RNA medicine are obvious, with the ease and speed of design […]
In Depth 10 Jul 2023
Making an impact through targeting mRNA
Biotech company Molecure develops small molecule therapies that can regulate RNA and underexplored protein targets for the treatment of incurable diseases, including cancer and fibrotic and inflammatory diseases. The company, which was named as one of our 10 biotech companies leading the charge in Poland, told Labiotech that its RNA platform finds small molecules that […]
In Depth 10 Jul 2023
Unleashing the potential: Optimizing mRNA for the discovery of transformative medicines
By Dr. Alexander Zehnder, CEO, CureVac The success of mRNA vaccines in COVID-19 propelled the role of this new modality to the forefront of medicine. Not only are new prophylactic mRNA vaccines for various respiratory diseases advancing through clinical development, but mRNA medicines are now being developed in many wide-ranging applications, including cancer and rare […]
ADVERTISEMENT
